This is a controlled document. If you are using a printed copy, check it against the guidelines site to ensure you are using the latest edition. Print copies must be destroyed after use.

This is a controlled document. If you are using a printed copy, check it against the guidelines site to ensure you are using the latest edition. Print copies must be destroyed after use.

| Version: | 3.0 |
|---|---|
| Guidelines Lead(s): | Jas Kalsi, Consultant Urology |
| Contributor(s): | Marc Laniado, Consultant Urology |
| Lead Director / Chief of Service: | Ian Laidlaw, Chief of Service, General Surgery and Urology |
| Library check completed: | N/A |
| Ratified at: | Urology Clinical Governance Group 16/04/2024 |
| Date Issued: | 21/06/2024 |
| Review Date: | 16/04/2027 |
| Pharmaceutical dosing advice and formulary compliance checked by: | Eftikhar Mohamed 07/06/2024 |
| Key words: | Retention, Urinary |
This guideline has been registered with the trust. However, clinical guidelines are guidelines only. The interpretation and application of clinical guidelines will remain the responsibility of the individual clinician. If in doubt contact a senior colleague or expert. Caution is advised when using guidelines after the review date. This guideline is for use in Frimley Health Trust hospitals only. Any use outside this location will not be supported by the Trust and will be at the risk of the individual using it.
Version Control Sheet
| Version | Date | Guideline Lead(s) | Status | Comment |
|---|---|---|---|---|
| 1.0 | June 2007 | Consultant Urologist | Final | |
| 2.0 | August 2014 | Consultant Urologist | Final | |
| 2.1 | September 2018 | Consultant Urologist | Interim | |
| 2.2 | June 2022 | Clinical Guidelines Administrator | Interim | Transferred to new Clinical Guidelines Template |
| 3.0 | April 2024 | Consultant Urologist | Final | Review |
Related Documents
| Document Type | Document Name |
|---|---|
| None |